Yuxuan Wang

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• A Genetically Encoded Calcium Ion Biosensor with an Exceptionally Large Ratiometric Response

  ACS Sensors · 2026-06-16

• Evaluation of Anticancer Therapy‐Related Tumor Flare Reaction: Insights From Food and Drug Administration's Adverse Event Reporting System Dataset

  Cancer Medicine · 2026-03-01 · 1 citations

• Camouflage of hyperdivergent Class II malocclusion using 3 maxillary miniscrews and a mandibular intrusion arch

  AJO-DO Clinical Companion · 2026-03-01

• Hierarchically Targeting and ROS-Responsive Platform for Diabetic Periodontitis Treatment through Mitochondrial Repair in M1 Macrophages

  ACS Applied Materials & Interfaces · 2025-12-28

• Development and Validation of an Artificial Intelligence Surgical Video Analysis Model for Predicting Visceral Pleural Invasion in Lung Cancer Surgery: A Multicenter Study

  Annals of Surgical Oncology · 2025-12-22 · 1 citations

• Figure S9 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S4 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Supplementary Notes 1-5 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S3 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S7 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S2 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S1 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S5 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S8 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S6 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Figure S10 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Supplementary Tables S1 and S2 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

  2025-12-12

• Measuring minimal residual AML in remission using a novel multi DNA mutation based next generation sequencing assay

  Blood · 2025-11-03

• Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial

  Nature Medicine · 2025-10-20 · 40 citations

• Transformer-based deep learning architecture for multivariable radioactive source term inversion

  Journal of Environmental Radioactivity · 2025-10-12 · 1 citations